GSK soothes investors by settling first Zantac cancer lawsuit due for US trial – GSK (GSK.L) reached an agreement to settle the U.S. lawsuit alleging its discontinuation of the heartburn medication Zantac led to cancer, the British drugmaker announced on Friday.
![GSK settles first Zantac cancer lawsuit, soothes investors. 1 gsk-zantac-lawsuit](https://thejusticenow.com/wp-content/uploads/2023/06/gsk.webp)